Center for Environmentally
Beneficial Catalysis

  • Home
  • ACS e-Book Chapter Authored by CEBC Faculty One of Top 10 Most-Read

ACS e-Book Chapter Authored by CEBC Faculty One of Top 10 Most-Read

Thursday, September 4, 2014

ACS Symposium Series LogoThe American Chemical Society publishing group recently reported that a chapter co-authored by three faculty members at the University of Kansas Center for Environmentally Beneficial Catalysis was one of the top 10 most read electronic book chapters of 2013.  

Juan Bravo-Suarez, assistant professor of chemical engineering, was lead author for the chapter and headed the editorial team for the electronic book Novel Materials for Catalysis and Fuels ProcessingSeveral other CEBC researchers and a former student contributed chapters to the book as well.

ACS e-Books have seen more than 2.5 million downloads since 2009 by scientists from around the world.  Bravo-Suarez’s peer-reviewed book is part of the ACS Symposium Series. According to the website, “Each chapter is carefully authored by an expert in the field, and the collection of chapters edited by an internationally recognized leader in the field.”

Design of Heterogeneous Catalysts for Fuels and Chemicals Processing: An Overview, by Juan J. Bravo-Suárez, Raghunath V. Chaudhari, and Bala Subramaniam

CEBC Calendar

November 7, Tuesday - CEBC Industry Colloquium
Brandon Emme, Cellulose Team Leader, ICM, Inc.
"From Moonshining to Molecules: How ICM is moving farms to biotech"
9:00 a.m. - 10:00 a.m., 1501 Wakarusa Drive, Building B seminar room
10:00 a.m. discussion with students

November 8, Wednesday - Mandatory Lab Safety Meeting
All researchers at 1501 Wakarusa Dr. must attend

9:00 a.m. in Building B seminar room

December 5, Tuesday - CEBC Industry Colloquium
Dr. John Warner, President & Chief Technology Officer, Warner Babcock Institute for Green Chemistry
"Title TBA"

11:00 a.m. - 12:00 p.m., Spahr Auditorium, 2 Eaton Hall, 1520 W. 15th Street

KU Today
48 nationally ranked graduate programs.
—U.S. News & World Report
Pharmacy school No. 2 nationally for NIH funding